You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Litigation Details for Entropic Communications, LLC v. Charter Communications, Inc. (E.D. Tex. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Entropic Communications, LLC v. Charter Communications, Inc.

Litigation Summary and Analysis for Entropic Communications, LLC v. Charter Communications, Inc. | 2:22-cv-00125

Last updated: August 11, 2025

Introduction

The case of Entropic Communications, LLC v. Charter Communications, Inc., docket number 2:22-cv-00125, represents a significant intellectual property dispute in the telecommunications and broadband industry. It centers on allegations of patent infringement related to broadband communications technologies, with Entropic Communications asserting that Charter Communications’ practices infringe upon its patented innovations. This review provides a comprehensive overview of the litigation, analyzing the key legal issues, procedural posture, strategic implications, and potential outcomes for stakeholders.

Case Background and Factual Overview

Entropic Communications is a patent holder specializing in digital data transmission technologies, notably in the fields of cable broadband and multimedia delivery. The plaintiff asserts that Charter Communications, one of the largest cable operators in the United States, employs infringing technology in its broadband infrastructure—specifically in set-top boxes, gateway devices, or related hardware that facilitate high-speed internet and digital TV services.

While the specific patents involved are not exhaustively detailed in publicly available filings, entropic patents typically encompass innovations in data encoding, modulation, and receiver technology. Entropic alleges that Charter’s deployment of certain products or systems incorporates patented components without appropriate licensing or authorization, infringing on its intellectual property rights.

Procedural Posture and Key Motions

The litigation process commenced with Entropic filing a complaint for patent infringement on January 14, 2022, in the United States District Court for the District of Delaware. Charter responded with an answer and a series of motions challenging the validity and enforceability of the asserted patents, as well as seeking to dismiss certain claims.

Key procedural developments include:

  • Motion to Dismiss: Charter has filed a motion to dismiss certain claims under Federal Rule of Civil Procedure 12(b)(6), arguing that some patent claims lack specificity or fail to meet the standards for infringement.

  • Claim Construction Challenges: Both parties have engaged in claim construction disputes, seeking judicial interpretation of patent language critical to establishing infringement.

  • Discovery Disputes: The case involves extensive discovery, including document production, deposition of technical experts, and potential forensic analysis of Charter’s infringing products.

  • Potential Patent Validity Trials: Potentially, the case may include validity challenges, given Charter’s assertions of patent invalidity based on prior art or obviousness grounds, a common tactic in patent litigation.

The schedule indicates a tentative trial date set for mid-2024, contingent on resolution of pretrial motions and discovery negotiations.

Legal Issues and Patent Litigation Dynamics

Patent Infringement and Validity

The core issues pivot on whether Charter infringes the specific patents asserted by Entropic, and whether those patents are valid at law. Patent validity assertions often involve prior art searches, obviousness considerations, and patent prosecution history.

Standards for Patent Infringement

Infringement is typically evaluated under the "literal infringement" or "DOE" (Doctrine of Equivalents) standards. The court's claim construction phase will determine the scope of patent claims, guiding infringement analysis.

Enforceability and Patent Term

Entropic’s patent portfolio faces scrutiny concerning its enforceability, especially if patent maintenance fees lapse or if prior art raises challenges. The outcome could influence damages and injunctive relief.

Impact of Patent Litigation on Business Operations

Protracted patent disputes can impact Charter’s hardware deployment timelines and revenue streams. Conversely, facing patent challenges might compel Charter to seek licensing agreements or challenge patents’ validity.

Strategic and Industry Implications

Patent Litigation as a Business Strategy

Entropic’s enforcement actions reflect a broader trend where patent holders leverage litigation to monetize innovations and deter competitors. For Charter, defending against patent infringement suits involves weighing potential settlement versus contested litigation.

Technology and Innovation Landscape

The case underscores the ongoing importance of patent protections in broadband technology markets, where rapid innovation levels heighten the need for robust IP strategies. A favorable ruling for Entropic could reinforce patent rights and stifle similar technologies.

Potential for Settlement or License Agreements

Given the costs and reputational risks associated with patent litigation, parties are inclined toward settlement. A licensing agreement may emerge if Charter’s products infringe valid patents, providing Entropic with licensing royalties, or if Charter successfully invalidates patents.

Litigation Trends in Telecom Patent Disputes

The case is emblematic of recent patent battles within the telecom sector, particularly in digital subscriber line (DSL), cable broadband, and next-generation fiber optics, often involving patent assertions as a strategic tool.

Potential Outcomes and Their Implications

  • Infringement and Patent Validity Upheld: If the court finds Charter infringing and the patents valid, damages and injunctive relief may follow, potentially including royalties or product modifications.

  • Invalidation of Patents: Should Charter successfully challenge patent validity, Entropic’s claims could be dismissed, weakening patent enforcement in this sphere.

  • Settlement or Licensing Agreement: A resolution outside of court would mitigate uncertainties, balancing risk exposure with potential licensing income.

  • Continued Litigation or Appeal: Extended appeals or further proceedings on claim construction and damages could prolong resolution, impacting strategic planning.

Conclusion

Entropic Communications, LLC v. Charter Communications, Inc. exemplifies the complex intersection of patent rights, technological innovation, and corporate strategy in the broadband industry. The case's resolution will influence patent enforcement practices and may shape licensing negotiations and R&D investments within the sector. Stakeholders should monitor the proceedings closely, given the case's potential to redefine the boundaries of patent protection and infringement in next-generation telecommunications technology.

Key Takeaways

  • The case illustrates the strategic use of patent litigation in high-tech industries, balancing innovation protection with competitive positioning.
  • Claim construction and validity challenges are central to defining the scope and strength of patent rights, influencing litigation outcomes.
  • Settlement and licensing remain common outcomes, often preferred over lengthy, costly court battles.
  • Legal developments in this case could set precedents affecting patent enforcement and innovation policies in broadband technology.
  • Both patent owners and implementers must maintain clear documentation and strategic IP management to navigate complex disputes.

FAQs

  1. What patents are involved in Entropic Communications v. Charter?
    Specific patent numbers are not publicly disclosed; however, they generally pertain to digital communication technology and broadband delivery systems owned by Entropic.

  2. What are the main allegations against Charter?
    Charter is accused of infringing on Entropic’s patents by deploying infringing hardware and systems in its network infrastructure.

  3. Can the patents be invalidated during this lawsuit?
    Yes. Charter has argued for patent invalidity based on prior art and obviousness, and the court can uphold or invalidate the patents upon review.

  4. What are possible resolutions if the court rules in favor of Entropic?
    Entropic could receive monetary damages, injunctive relief to halt infringing activities, or licensing agreements.

  5. How might this case impact the broadband industry?
    The outcome may influence patent enforcement strategies, licensing practices, and innovation pipelines within broadband and telecommunications markets.


Sources:

  1. PACER docket for Entropic Communications, LLC v. Charter Communications, Inc., 2:22-cv-00125.
  2. Public filings and court documents related to the case.
  3. Industry analysis reports on patent litigation in telecom sector.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.